

Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Leadless pacemaker implantation techniques for micra
Typology: Summaries
1 / 2
This page cannot be seen from the preview
Don't miss anything!


This document summarizes the practical procedural workflow, handle controls, locking mechanism, and troubleshooting points during implantation of the Medtronic Micra leadless pacemaker system.
Right femoral venous access is commonly preferred. Initial puncture is often obtained using micropuncture technique followed by serial dilation. Final introducer sheath size is approximately 27F outer diameter and 23F inner diameter. Because the sheath is large, ultrasound-guided access and careful venous puncture are important to avoid vascular complications.
A stiff guidewire such as an Amplatz Super Stiff wire is advanced into the SVC. The large introducer sheath is then positioned into the right atrium. The Micra delivery catheter is advanced through the sheath into the RA, across the tricuspid valve, and into the right ventricle.
Preferred implantation site is usually the RV septum or apical septal region. Free wall deployment should be avoided because of perforation risk. Fluoroscopic RAO and LAO views help confirm septal positioning.
The delivery handle contains multiple control systems:
A. Deflection Control: Used to flex and steer the catheter toward the RV septum.
B. Deployment Mechanism: Used to deploy the nitinol fixation tines into myocardium.
C. Locking Button / Lock Switch: A safety mechanism that prevents accidental deployment or unintended release of the device. It stabilizes the tether and deployment system during positioning and recapture. The lock essentially keeps the system in a “safe” state until intentional deployment and release are desired.
The locking system prevents premature release of the device while the operator is still evaluating fixation and electrical parameters. Before final release, the Micra remains attached to a tether and can still be recaptured and repositioned.
After deployment, a gentle pull-and-hold maneuver (“tug test”) is performed. Ideally at least two tines should appear engaged before final release. Poor engagement requires recapture and repositioning.
If thresholds are high, sensing is poor, or fixation is unstable, the device can be recaptured by advancing the recapture cone and pulling the tether. The Micra collapses back into the catheter and may be repositioned multiple times before final release.
Difficulty crossing tricuspid valve: Reduce deflection, withdraw slightly, rotate catheter, or use RA looping technique.
High thresholds: Reposition away from trabeculated or scarred regions.
Low sensing: Reposition away from scar or extreme apex.
Poor tug test: Do not release. Recapture and reposition.
Perforation warning signs: Hypotension, pericardial effusion, chest pain, or sudden instability during deployment.
Final release is performed only after acceptable fixation, threshold, sensing, and impedance are confirmed. The tether is detached, the delivery system is removed, and femoral hemostasis is achieved.